Abstract
Background: In today’s context when liver diseases have spread across countries and people of all ages, it is of high importance to consider novel methods of non-toxic and long lived therapeutics. Among various therapies, immunotherapy for acute and chronic liver diseases is rapidly moving to the forefront among treatment options in hepatology medicine.
Objective: The present review covers the recent advances in immunotherapy of hepatocellular carcinoma (HCC), viral hepatitis, cirrhosis, obesity induced inflammation, non alcoholic fatty liver diseases (NAFLD), and drug induced liver injury (DILI) and disease pertaining to autoimmunity in liver. Methods: A Literature search pertaining to liver immune tolerance and various immunotherapies using the major scientific databases on preclinical studies as well as clinical trials and meta-analysis were analyzed to know about the tolerance and immunotherapy of liver diseases. Results: Immunotherapy in liver might be problematic owing to the immune tolerance property of liver. The key to therapeutic approach by utilizing this immune biology of liver is based on harnessing the immunomodulatory techniques to achieve immune activity or inhibition. Therefore, it is a necessity to overcome this immune tolerance for effective immunotherapeutic strategies. Immunotherapy may also help to boost and enhance the immunity of patients against liver diseases in combination with conventional treatment methods, or more than one method in immunotherapy may produce synergistic effect and prove to be better than when applied alone. Conclusion: Liver has a unique immuno- biological advantage which is utilized to maintain a balance between immunity and tolerance. This intricate balance of hepatic immune cells can be modulated to effect treatments in various liver diseases. However it is important to maintain a balance between the immunity of the liver and its modulation to provide protection against hepatic disease. The key to successful curing of these conditions lies along this fine line of manipulating liver immune cells for our own benefit.Keywords: Alcoholic liver disease, DILI, HCC, immunotherapy, liver diseases, NAFLD.
Graphical Abstract
Current Drug Metabolism
Title:Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance
Volume: 17 Issue: 10
Author(s): Alaknanda Mishra, Pramod K. Upadhyay and Perumal Nagarajan
Affiliation:
Keywords: Alcoholic liver disease, DILI, HCC, immunotherapy, liver diseases, NAFLD.
Abstract: Background: In today’s context when liver diseases have spread across countries and people of all ages, it is of high importance to consider novel methods of non-toxic and long lived therapeutics. Among various therapies, immunotherapy for acute and chronic liver diseases is rapidly moving to the forefront among treatment options in hepatology medicine.
Objective: The present review covers the recent advances in immunotherapy of hepatocellular carcinoma (HCC), viral hepatitis, cirrhosis, obesity induced inflammation, non alcoholic fatty liver diseases (NAFLD), and drug induced liver injury (DILI) and disease pertaining to autoimmunity in liver. Methods: A Literature search pertaining to liver immune tolerance and various immunotherapies using the major scientific databases on preclinical studies as well as clinical trials and meta-analysis were analyzed to know about the tolerance and immunotherapy of liver diseases. Results: Immunotherapy in liver might be problematic owing to the immune tolerance property of liver. The key to therapeutic approach by utilizing this immune biology of liver is based on harnessing the immunomodulatory techniques to achieve immune activity or inhibition. Therefore, it is a necessity to overcome this immune tolerance for effective immunotherapeutic strategies. Immunotherapy may also help to boost and enhance the immunity of patients against liver diseases in combination with conventional treatment methods, or more than one method in immunotherapy may produce synergistic effect and prove to be better than when applied alone. Conclusion: Liver has a unique immuno- biological advantage which is utilized to maintain a balance between immunity and tolerance. This intricate balance of hepatic immune cells can be modulated to effect treatments in various liver diseases. However it is important to maintain a balance between the immunity of the liver and its modulation to provide protection against hepatic disease. The key to successful curing of these conditions lies along this fine line of manipulating liver immune cells for our own benefit.Export Options
About this article
Cite this article as:
Mishra Alaknanda, Upadhyay K. Pramod and Nagarajan Perumal, Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance, Current Drug Metabolism 2016; 17 (10) . https://dx.doi.org/10.2174/1389200218666161116120301
DOI https://dx.doi.org/10.2174/1389200218666161116120301 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Mitochondria, Cellular Stress Resistance, Somatic Cell Depletion and Lifespan
Current Aging Science Targeting the Chemokines in Cardiac Repair
Current Pharmaceutical Design ADAM10 as a Therapeutic Target for Cancer and Inflammation
Current Pharmaceutical Design Heme Oxygenase-1: A Potential Antihypertensive Target?
Current Hypertension Reviews Adjudin - A Male Contraceptive with Other Biological Activities
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Current Pharmaceutical Design Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets Brain Perfusion In Sepsis
Current Vascular Pharmacology Albumin Induces Neuroprotection Against Ischemic Stroke by Altering Toll-Like Receptor 4 and Regulatory T Cells in Mice
CNS & Neurological Disorders - Drug Targets The Bax Inhibitor-1 (BI-1) Family in Apoptosis and Tumorigenesis
Current Molecular Medicine Synthesis and Characterization of a Nylon/Titanium as Hybrid Biomaterial
Recent Patents on Corrosion Science Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology
Current Drug Discovery Technologies Neuroprotective Effects of Trolox, Human Chorionic Gonadotropin, and Carnosic Acid on Hippocampal Neurodegeneration After Ischemiareperfusion Injury
Current Stem Cell Research & Therapy In Search of Novel and Therapeutically Significant Melatoninergic Ligands
Recent Patents on CNS Drug Discovery (Discontinued) Therapeutic Hypothermia in Brain Injuries and Related Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological and Biological Activities of Xanthones
Anti-Infective Agents in Medicinal Chemistry Pre-Emptive Conditioning of the Ischemic Heart
Cardiovascular & Hematological Agents in Medicinal Chemistry Efficient Expression and Purification of Recombinant Therapeutic Protein Candidates, Human Midkine and Pleiotrophin
Current Pharmaceutical Biotechnology